Skip to content
← Full study record

NCT00387348 · MORE INFO

Limitations, agreements, and source contact

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer · Source last updated 2012-12-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
restrictive Agreement
false
limitations And Caveats
description
After an interim analaysis, the DSMB decided to terminate the trial early because of the rate of adverse events (HAM-D scores increasing by at least 25%) and deaths were higher in participants receiving placebo.
point Of Contact
email
wpirl@partners.org
organization
Massachusetts General Hospital
phone
617-724-9151
title
William F Pirl, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
restrictive Agreement
false
limitations And Caveats
description
After an interim analaysis, the DSMB decided to terminate the trial early because of the rate of adverse events (HAM-D scores increasing by at least 25%) and deaths were higher in participants receiving placebo.
point Of Contact
email
wpirl@partners.org
organization
Massachusetts General Hospital
phone
617-724-9151
title
William F Pirl, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice